Alimera Sciences Inc reports results for the quarter ended in March - Earnings Summary

Alimera Sciences

15/05/2023 14:32

* Alimera Sciences Inc  ALIM.OQ  reported a quarterly
adjusted
loss of 71 cents​​ per share for the quarter ended in March. The
mean expectation of three analysts for the quarter was for a
loss of 51 cents per share.
    * Revenue rose 13.9% to $13.55 million from a year ago;
analysts
expected $12.30 million. 
    * Alimera Sciences Inc's reported EPS for the quarter was a
loss
of 71 cents​.
    * The mean earnings estimate of analysts had fallen by
about 8.4%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Alimera Sciences Inc shares had fallen by 22.9% this
quarter and
lost 40.2% so far this year.
    * The company reported a quarterly loss of $4.97 million.
    * Wall Street's median 12-month price target for Alimera
Sciences
Inc is $8.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
15 at 01:32 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.51          -0.71          Missed
 Dec. 31 2022      -0.33          -0.54          Missed
 Sep. 30 2022      -0.40          -0.75          Missed
 Jun. 30 2022      -0.55          -0.45          Beat